- Home
- AMPY vs IMRX Comparison
AMPY vs IMRX Comparison
Compare AMPY & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMPY
- IMRX
- Stock Information
- Founded
- AMPY 2011
- IMRX 2008
- Country
- AMPY United States
- IMRX United States
- Employees
- AMPY N/A
- IMRX N/A
- Industry
- AMPY Oil & Gas Production
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- AMPY Energy
- IMRX Health Care
- Exchange
- AMPY Nasdaq
- IMRX Nasdaq
- Market Cap
- AMPY 203.1M
- IMRX 232.9M
- IPO Year
- AMPY 2011
- IMRX 2021
- Fundamental
- Price
- AMPY $4.73
- IMRX $6.13
- Analyst Decision
- AMPY Strong Buy
- IMRX Strong Buy
- Analyst Count
- AMPY 1
- IMRX 4
- Target Price
- AMPY $11.00
- IMRX $17.75
- AVG Volume (30 Days)
- AMPY 2.2M
- IMRX 3.5M
- Earning Date
- AMPY 11-05-2025
- IMRX 11-12-2025
- Dividend Yield
- AMPY N/A
- IMRX N/A
- EPS Growth
- AMPY N/A
- IMRX N/A
- EPS
- AMPY 0.38
- IMRX N/A
- Revenue
- AMPY $279,289,100.00
- IMRX N/A
- Revenue This Year
- AMPY $1.83
- IMRX N/A
- Revenue Next Year
- AMPY N/A
- IMRX N/A
- P/E Ratio
- AMPY $13.82
- IMRX N/A
- Revenue Growth
- AMPY N/A
- IMRX N/A
- 52 Week Low
- AMPY $2.27
- IMRX $1.10
- 52 Week High
- AMPY $7.23
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- AMPY 48.89
- IMRX 46.17
- Support Level
- AMPY $4.86
- IMRX $6.06
- Resistance Level
- AMPY $5.44
- IMRX $6.62
- Average True Range (ATR)
- AMPY 0.42
- IMRX 0.86
- MACD
- AMPY -0.06
- IMRX -0.30
- Stochastic Oscillator
- AMPY 14.24
- IMRX 2.48
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.